Avantor® Provides First Look at Recently Completed Hydration Expansion at DCAT Week 2025

17.03.25 12:05 Uhr

Werte in diesem Artikel

Facility in Gliwice, Poland to boost biopharma manufacturers' efficiency and speed to market of therapies

RADNOR, Pa., March 17, 2025 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services in the life sciences and advanced technology industries, announces that Ger Brophy, PhD, head of Avantor's Scientific Advisory Board, will present highlights of the recently completed expansion at its flagship European manufacturing site at Drug, Chemical & Associated Technologies Association (DCAT) Week 2025. Dr. Brophy's presentation will take place as part of the Member Company Announcement Forum on Monday, March 17, at approximately 9:15 am eastern. DCAT Week, which runs March 17 – 20 in New York City, is the premier annual event for companies engaged in the Global Bio/Pharmaceutical Manufacturing Value Chain. 

Avantor. Setting science in motion to create a better world. (PRNewsfoto/Avantor)

The new production facility's advanced technologies quadruple the site's capacity for manufacturing, formulating, and filling United States Pharmacopoeia (USP) purified water and Water for Injection (WFI)-based hydration solutions. These high-purity solutions are essential in buffer preparations, cell culture media, clean-in-process (CIP), and formulation processes, supporting the stability, efficacy, and safety of biologics and other life-saving therapies.

"This latest investment strengthens our global manufacturing network, building important capacity and bringing our operations closer to customers," said Benoit Gourdier, EVP of Avantor's Bioscience Production Segment. "It ensures a dependable supply of high-quality products while strengthening our role as a trusted partner, working alongside biopharma manufacturers to produce life changing therapies." 

In recent years, Avantor has made substantial investments to enhance global production capacity and introduce new products to serve the growing bioprocessing needs of drug manufacturers. This project in Poland builds on a recent expansion at the Aurora, Ohio manufacturing site, which added significant hydrated solutions capacity to support the North American market. Additionally, a new production facility at the Phillipsburg, N.J. manufacturing site has doubled the output of synthesized salts, a vital ingredient in hydration manufacturing. These investments improve Avantor's global production efficiency, optimize supply chain operations and strengthen the availability of raw materials for biopharma applications to customers worldwide. 

In addition to increasing manufacturing capacity, Avantor has also expanded its research and innovation capabilities. In November 2024, the company opened its new 60,000-square-foot Bridgewater Innovation Center in New Jersey doubling its previous lab and pilot plant capacity, enhancing collaboration and bioprocessing innovation. Designed for upstream and downstream development, analytical testing, and viral vector research, the state-of-the-art facility accelerates scale-up and customization across the entire bioprocessing workflow. 

About Avantor
Avantor® is a leading life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. We work side-by-side with customers at every step of the scientific journey to enable breakthroughs in medicine, healthcare, and technology. Our portfolio is used in virtually every stage of the most important research, development, and production activities at more than 300,000 customer locations in 180 countries. For more information, visit avantorsciences.com and find us on LinkedIn, X (Twitter), and Facebook.

Global Media Contact
Eric Van Zanten
Head of External Communications
Avantor
610-529-6219
Eric.VanZanten@avantorsciences.com

Investor Relations Contact
Allison Hosak
Senior Vice President, Global Communications
Avantor
908-329-7281
Allison.Hosak@avantorsciences.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/avantor-provides-first-look-at-recently-completed-hydration-expansion-at-dcat-week-2025-302402531.html

SOURCE Avantor and Financial News

In eigener Sache

Übrigens: Avantor und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf Avantor

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Avantor

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Nachrichten zu Avantor Inc Registered Shs

Wer­bung

Analysen zu Avantor Inc Registered Shs

DatumRatingAnalyst
11.06.2019Avantor OverweightBarclays Capital
11.06.2019Avantor BuyDeutsche Bank AG
11.06.2019Avantor OutperformCowen and Company, LLC
DatumRatingAnalyst
11.06.2019Avantor OverweightBarclays Capital
11.06.2019Avantor BuyDeutsche Bank AG
11.06.2019Avantor OutperformCowen and Company, LLC
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Avantor Inc Registered Shs nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen